Essential cookies by default. The browser ID, load-time metrics and error replays only run if you choose "Accept all".
Head-to-head evidence comparison — which supplement is right for you?
Clascoterone vs Salicylic Acid (topical): they're closely matched on evidence (7 vs 5/10); they're alternatives for clearer skin (acne) — the best pick depends on your goals. Take the 2-minute quiz for a pick tailored to your goals.
Clascoterone and Salicylic Acid (topical) are closely matched across evidence, studies, and safety.
Verdict
Too few graded studies
Top outcomes
Verdict
Too few graded studies
0 of 1 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (2)
Outcomes where both Clascoterone and Salicylic Acid (topical) have evidence — compare verdict strength side-by-side.
A source-matched dose range is not available for this product and use.
If this treatment was prescribed for you, follow your prescriber’s directions. Do not change prescribed treatment because this page has no matched dose range.
Morning and evening
Clascoterone 1% cream
Topical OTC use. Leave-on and wash-off acne products contain 0.5-2% salicylic acid, applied to affected areas once or twice daily and built up as tolerated; professional peels (20-30%) are applied in-office. There is no oral or systemic dose in this context — it is not ingested (and large-area/high-concentration use can cause systemic salicylate absorption, so follow label limits). This library does not provide an ingestion protocol.
Any time of day
Leave-on or wash-off acne product (0.5-2% salicylic acid)
immediate
12 weeks
12 weeks
1-4 weeks
Throughout
4-12 weeks
4-12 weeks
Throughout
Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne: Two Phase 3 Randomized Clinical Trials
JAMA Dermatol (2020) · RCT · n=1440
The pivotal registration trials: two identical phase 3 studies, 1440 patients randomised, conducted November 2015 to April 2018.
Efficacy and Safety of 1% Clascoterone Cream in Patients Aged > 12 Years With Acne Vulgaris
J Drugs Dermatol (2023) · RCT · n=1421
709 patients received clascoterone and 712 received vehicle in the pooled ≥12-year population.
Efficacy and safety of topical clascoterone cream for treatment of acne vulgaris: A systematic review and meta-analysis of randomized placebo-controlled trials
Dermatol Ther (2021) · Meta-Analysis · n=2457
Five trials, 2457 patients (1357 clascoterone, 1100 placebo), overall low risk of bias.
Comparison of alpha- and beta-hydroxy acid chemical peels in the treatment of mild to moderately severe facial acne vulgaris.
Dermatol Surg (2008) · RCT · n=20
Split-face, double-blind RCT (n=20) comparing 30% salicylic acid vs 30% glycolic acid peels, six treatments at 2-week intervals
Comparison of chloroxylenol 0.5% plus salicylic acid 2% cream and benzoyl peroxide 5% gel in the treatment of acne vulgaris: a randomized double-blind study.
Drugs Exp Clin Res (2003) · RCT · n=37
12-week double-blind RCT (n=37) comparing a 2% salicylic acid (plus chloroxylenol) cream vs benzoyl peroxide 5% gel twice daily
Comparative study of efficacy and safety of 45% mandelic acid versus 30% salicylic acid peels in mild-to-moderate acne vulgaris.
J Cosmet Dermatol (2020) · RCT · n=50
Randomized trial (n=50) of 30% salicylic acid vs 45% mandelic acid peels, six sessions over 12 weeks for mild-to-moderate acne
Both Clascoterone and Salicylic Acid (topical) are closely matched — the best choice depends on your specific health goals.
For clearer skin (acne), Clascoterone has a higher relevance score (92 vs 75).
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.